Your browser doesn't support javascript.
loading
Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV.
Reilly, Cavan S; Borges, Álvaro H; Baker, Jason V; Safo, Sandra E; Sharma, Shweta; Polizzotto, Mark N; Pankow, James S; Hu, Xiaojun; Sherman, Brad T; Babiker, Abdel G; Lundgren, Jens D; Lane, H Clifford.
  • Reilly CS; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Borges ÁH; Immunology, Statens Serum Institut, Copenhagen, Denmark.
  • Baker JV; HIV Medicine, Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota, USA.
  • Safo SE; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Sharma S; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Polizzotto MN; Department of Medicine, Australian National University, Canberra, Australia.
  • Pankow JS; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Hu X; Animal and Plant Inspection Service, US Department of Agriculture, Beltsville, Maryland, USA.
  • Sherman BT; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratories, Frederick, Maryland, USA.
  • Babiker AG; Epidemiology and Medical Statistics, University College London, London, United Kingdom.
  • Lundgren JD; Department of Infectious Diseases, University of Copenhagen, Copenhagen, Denmark.
  • Lane HC; Division of Clinical Research, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
J Infect Dis ; 227(8): 951-960, 2023 04 18.
Article en En | MEDLINE | ID: mdl-36580481
ABSTRACT

BACKGROUND:

There is an incompletely understood increased risk for cardiovascular disease (CVD) among people with HIV (PWH). We investigated if a collection of biomarkers were associated with CVD among PWH. Mendelian randomization (MR) was used to identify potentially causal associations.

METHODS:

Data from follow-up in 4 large trials among PWH were used to identify 131 incident CVD cases and they were matched to 259 participants without incident CVD (controls). Tests of associations between 460 baseline protein levels and case status were conducted.

RESULTS:

Univariate analysis found CLEC6A, HGF, IL-6, IL-10RB, and IGFBP7 as being associated with case status and a multivariate model identified 3 of these CLEC6A (odds ratio [OR] = 1.48, P = .037), HGF (OR = 1.83, P = .012), and IL-6 (OR = 1.45, P = .016). MR methods identified 5 significantly associated proteins AXL, CHI3L1, GAS6, IL-6RA, and SCGB3A2.

CONCLUSIONS:

These results implicate inflammatory and fibrotic processes as contributing to CVD. While some of these biomarkers are well established in the general population and in PWH (IL-6 and its receptor), some are novel to PWH (HGF, AXL, and GAS6) and some are novel overall (CLEC6A). Further investigation into the uniqueness of these biomarkers in PWH and the role of these biomarkers as targets among PWH is warranted.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Infecciones por VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Infecciones por VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article